Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our strategy employs molecular simulations to explore an extensive range of proteins, capturing their dynamics both individually and within complexes with other proteins. Through ensemble virtual screening, we address proteins' conformational mobility, uncovering key binding sites at both functional regions and remote allosteric locations. This comprehensive investigation ensures a thorough assessment of all potential mechanisms of action, with the goal of discovering innovative therapeutic targets and lead molecules across across diverse biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
P78543
UPID:
BTG2_HUMAN
Alternative names:
BTG family member 2; NGF-inducible anti-proliferative protein PC3
Alternative UPACC:
P78543; A0A024R986; Q3KR25; Q5VUT0
Background:
Protein BTG2, also known as BTG family member 2 or NGF-inducible anti-proliferative protein PC3, plays a crucial role in cellular processes. It is an anti-proliferative protein that functions through its association with the CCR4-NOT complex, activating mRNA deadenylation in a CNOT6 and CNOT7-dependent manner. This protein is involved in cell cycle regulation, growth arrest, and differentiation of neuronal precursors, and modulates transcription regulation mediated by ESR1. Additionally, it is linked to mitochondrial depolarization and neurite outgrowth.
Therapeutic significance:
Understanding the role of Protein BTG2 could open doors to potential therapeutic strategies.